New CDMO Amatsi-Avogadro formed
Amatsi and Avogadro have announced plans to team up and create what they claim will be the leading CDMO in France.
The new entity, named Amatsi Avogadro, will provide a range of development and analytical services as well as manufacturing, packaging and distribution services for clinical trials.
The firms generated combined turnover of €20m ($27.7m) in fiscal 2011 and together employ 175 staff at sites in Montpellier and Toulouse in France and Cambridge in the US.
Amatsi president Jean-Pascal Conduzorgues said teaming with Avogadro will provide “a larger range of facilities to our clients, increased development capabilities as well as a stronger quality assurance framework.”
